The University of Chicago Header Logo

Connection

Veeral Sheth to Complement Inactivating Agents

Back to Details
This is a "connection" page, showing publications Veeral Sheth has written about Complement Inactivating Agents.
Veeral Sheth
Connection Strength
0.206
Complement Inactivating Agents
  1. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet. 2023 Oct 21; 402(10411):1449-1458.
    View in: PubMed
    Score: 0.206
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.